Insider Trading June 26, 2026 04:06 PM

Telos Director Dockery Offloads $30,520 in Company Shares Amid Mixed Market Signals

Insider sale coincides with recent earnings beat and another director's transaction, highlighting shifting dynamics at the cybersecurity firm.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
TLS

Director Derrick Dockery executed a sale of 7,000 Telos Corp shares on June 24, 2026, totaling $30,520 at $4.36 per share. This transaction reduces his direct holdings to 179,591 shares. The sale follows a period of significant stock volatility, with the shares down 17% year-to-date despite a 42% annual gain. Concurrently, the company reported first-quarter 2026 earnings that exceeded expectations, yet the stock price declined post-release. Another director, Bradley W. Jacobs, also recently sold shares, adding to the insider activity scrutiny.

Telos Director Dockery Offloads $30,520 in Company Shares Amid Mixed Market Signals
TLS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Derrick Dockery sold 7,000 shares at $4.36 each, reducing direct holdings to 179,591 shares.
  • Telos reported Q1 2026 earnings of $0.06 per share and revenue of $47.7 million, beating forecasts.
  • Director Bradley W. Jacobs also sold 55,772 shares at $4.31 per share, per SEC filings.
Telos Corp (NASDAQ: TLS) director Derrick D. Dockery executed a transaction involving the sale of 7,000 shares of the company's common stock on June 24, 2026. The aggregate value of this divestment reached $30,520. Analysis of the transaction reveals the shares were disposed of at a unit price of $4.36. This execution price sits marginally below the stock's prevailing trading level of $4.50 at the time of reporting. The sale activity contributes to a broader narrative of insider movement at the cybersecurity provider. Following this specific transaction, Dockery's direct ownership position in Telos Corp common stock stands at 179,591 shares. Market performance metrics for Telos present a complex picture. Over the trailing twelve-month period, the equity has appreciated by 42%, indicating substantial long-term growth trajectory. Conversely, the current year-to-date performance reflects a contraction of 17%, suggesting recent downward pressure on valuation. Valuation assessments from InvestingPro analysis suggest the stock may currently trade below its intrinsic value. Analyst consensus price targets for TLS range between $4 and $9. Forward-looking financial projections indicate a potential return to profitability within the current fiscal year, with estimated earnings per share of $0.13. Recent corporate financial disclosures provide additional context to the insider activity. Telos Corp reported first-quarter 2026 financial results that demonstrated operational improvement. Earnings per share for the period came in at $0.06, significantly outperforming the consensus forecast which anticipated a loss of $0.01. Top-line revenue also surpassed expectations, recording $47.7 million against a projected $42.16 million. Despite these positive fundamental indicators, the market reaction was negative, with the stock price declining following the earnings release. Insider trading activity extends beyond Dockery's transaction. Director Bradley W. Jacobs also engaged in a significant divestment, selling 55,772 shares at a weighted average price of $4.31 per share. This transaction was formally documented in a filing submitted to the Securities and Exchange Commission. The convergence of positive earnings data, declining stock price, and concurrent insider sales has attracted attention from market participants and financial analysts. These developments highlight the dynamic interplay between corporate fundamentals and insider capital allocation strategies within the technology sector.

Risks

  • Stock price declined despite beating earnings expectations, indicating potential investor skepticism.
  • Year-to-date performance remains down 17%, suggesting ongoing market pressure on the valuation.
  • Concurrent insider sales by multiple directors may signal caution regarding near-term stock performance.

More from Insider Trading

PTC Therapeutics Executive Divests $2.25M in Stock via Pre-Arranged Plan Jun 26, 2026 BillionToOne CPO Executes Pre-Arranged Share Sale Amid Stock Appreciation Jun 26, 2026 CECO CFO Johansson Divests Shares Amid Merger-Driven Valuation Shift Jun 26, 2026 CECO Director Jason DeZwirek Offloads $6.59M in Shares Amid Valuation Questions Jun 26, 2026 Best Buy Chairman Emeritus Schulze Offloads $32.7M in Shares Amid Leadership Shift Jun 26, 2026